Click
here
to review the New Year operating hours.
x
Care In Numbers
Serving Our Community
Premarital Screening
Screen Today for a Healthier Tomorrow
Al Amal Initiative
Hope Begins Here
Baraem Initiative
Track Your Child's Big Milestones
Vaccination
Safeguard Your Health at Every Stage of Life
Telemedicine
Expert care, Anytime, Anywhere
Dawaee Initiative
Your prescription delivered to your doorstep
Reaya Initiative
Compassionate care in the comfort of your home
Blood Donation
Give the gift of life to someone in need
Organ Donation and Transplantation
Make a difference that lasts a lifetime
Connect with us anytime, anywhere.
Download Dubai Health App Now
Latest News & Events
Dubai Health and Johnson & Johnson MedTech have signed a Memorandum of Understanding (MoU) establishing a collaborative framework to advance professional education, drive sustainability initiatives, and support digital innovation in healthcare.
The MoU was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and Prosun Niyogi, Vice President and General Manager, Surgery Emerging Markets representing Johnson & Johnson MedTech. The signing was attended by Dr. Tarek Fathey, Chief Clinical Officer at Dubai Health.
The collaboration is structured around three core pillars. The first focuses on professional education and capacity building through tailored training programs and train-the-trainer initiatives. The second advances sustainable development by expanding recycling programs across selected hospitals. The third supports the implementation of digital ecosystems that enable surgical video capture, secure content sharing, collaborative case planning, and telepresence-enabled remote collaboration and education.
Dr. Hanan Al Suwaidi said: “This strategic partnership with Johnson & Johnson MedTech reflects our commitment to healthcare excellence through purpose-driven partnerships. Guided by our vision to advance health for humanity, we are building a framework that will enhance professional education, promote sustainability, and support digital innovation across our integrated academic health system.”
Dr. Tarek Fathey said: “This collaboration represents a significant milestone in advancing clinical practice across Dubai Health through the integration of advanced digital technologies into surgical environments and clinical education. It enhances precision in medical decision-making, strengthens multidisciplinary team capabilities, and ultimately contributes to improved patient outcomes.”
Prosun Niyogi said, “Dubai Health's 'Patient First' promise reflects the same principle that guides everything we do at Johnson & Johnson MedTech: putting the needs of patients above all else. This partnership allows us to pioneer new models of professional education, advance sustainable healthcare practices, and connect clinicians through digital innovation- all in service of one goal: removing limitations to a full life and changing the trajectory of health for communities across the UAE and beyond.”
The collaboration reflects a shared commitment to driving meaningful progress in healthcare through knowledge exchange, innovation, and strategic partnership, ultimately supporting better outcomes for patients and communities.
His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors, launched ‘The Cancer Fund’ of Al Jalila Foundation, the philanthropic arm of Dubai Health, in the presence of His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors.
His Highness also unveiled ‘The Giving Wall’ at Dubai Hospital, which bears the names of donors who have supported its treatment programmes, in recognition of their generosity.
The Cancer Fund aims to provide vital support for cancer treatment, helping ease the financial burden on patients and ensuring they can continue their care throughout recovery.
The launch of The Cancer Fund took place during a ceremony hosted by Al Jalila Foundation at Dubai Hospital, where His Highness Sheikh Ahmed bin Saeed Al Maktoum honoured partners, donors, and supporters of the hospital’s treatment programmes.
The ceremony was attended by His Excellency Mohammed Ibrahim Al Shaibani, Director General of HH the Dubai Ruler's Court; Her Excellency Dr. Raja Easa Al Gurg, Member of Dubai Health Board of Directors, and Chairperson of Al Jalila Foundation Board of Directors; His Excellency Dr. Alawi AlSheikh-Ali, Director General of the Dubai Health Authority; His Excellency Dr. Amer Sharif, CEO of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU); and other senior officials.
His Highness Sheikh Ahmed bin Saeed stated: “Giving is a deeply rooted value in the UAE instilled by our Founding Fathers and our leadership continues to build on this legacy through initiatives that place people’s health and wellbeing at the heart of national priorities.”
His Highness praised the individuals and institutions whose generosity strengthens community philanthropic efforts, noting that the strong engagement generated by such programmes reflects a shared national commitment to supporting people and enhancing quality of life.
Strategic step
Her Excellency Dr. Raja Easa Al Gurg said: “The Cancer Fund marks a strategic step towards building a sustainable support system for patients.”
She added: “The Fund also reflects a forward-looking model of collaboration, with community and institutional giving playing a central role in strengthening our healthcare system and expanding its impact on patients’ lives. We believe that sustainable philanthropy is essential to building a more cohesive society, where collective efforts come together to shape a better future for all.”
Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Dedicating this year’s Ramadan campaign at Al Jalila Foundation to The Cancer Fund will expand support pathways available to cancer patients. It reflects the role of community giving in helping patients access timely treatment, in line with Dubai Health’s ‘Patient First’ promise.”
He added: “The generosity of donors enabled us to provide care to 650 cancer patients over the past year, with contributions exceeding AED43 million through the ‘A’awen’ programme.
Al Jalila Foundation encourages individuals and organisations to support the Ramadan 2026 campaign through its donation channels, emphasising that every contribution makes a difference for patients and their families by helping them access treatment.
His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors, emphasised the importance of partnerships with leading academic health systems driven by scientific research and medical education to advance healthcare, elevate quality of care, strengthen patient safety standards, and build medical talent.
His Highness made these remarks during a meeting held on the sidelines of the World Health Expo (WHX) Dubai 2026, with Dr. Omar Lateef, President and CEO of Rush University System for Health and Rush University Medical Center, one of the world’s leading academic health systems. The meeting was attended by His Excellency Dr. Alawi AlSheikh-Ali, Director General of Dubai Health Authority, and His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences.
Rush University System for Health is ranked among the leading healthcare systems in the United States for quality, patient experience, and safety. It has received high ratings from patient safety regulators and is recognised for excellence across several medical specialties, including orthopedics, neurology, and cardiology.
One of the world’s leading healthcare exhibitions, WHX Dubai 2026 is taking place from 9 – 12 February at the Dubai Exhibition Centre (DEC).
Dubai Health Authority (DHA) and Dubai Health, represented by Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), have signed a Memorandum of Understanding (MoU) to advance the Emiratization of healthcare professions by supporting Emirati students enrolled in bachelor’s and master’s degree programs across various medical specializations at MBRU.
The MoU marks a significant step forward in a shared commitment to developing national healthcare talent. The signing ceremony was witnessed by His Excellency Dr. Alawi AlSheikh-Ali, Director General of Dubai Health Authority, and Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of MBRU.
Under the agreement, Dubai Health Authority will cover the tuition fees of a number of Emirati students enrolled in bachelor’s and master’s degree programs across various medical specializations at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the learning and discovery arm of Dubai Health, including programs offered by the Hind Bint Maktoum College of Nursing and Midwifery.
The MoU was signed by Dr. Asma Al Sharif, Acting CEO of the Health Regulation Sector at DHA, and Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and Provost of MBRU, during World Health Expo Dubai 2026.
Dr. Asma Al Sharif said: “The MoU provides significant momentum to our shared efforts to advance the Emiratization of healthcare professions and equip the health sector with highly qualified national talent capable of achieving the strategic goals of Dubai’s health system.”
Dr. Hanan Al Suwaidi said: “This MoU reflects our commitment, together with Dubai Health Authority, to cultivating highly qualified national medical talent to lead the future of Dubai’s healthcare sector. By empowering Emirati students academically and professionally in vital specializations, including nursing, we strengthen the integration of our academic health system.”
She added: “The program will support students enrolled in the Medicine and Surgery programs, as well as those of the Hind Bint Maktoum College of Nursing and Midwifery at MBRU, reinforcing essential healthcare career pathways.”
